In this episode, we are joined by Carol Stanfill the VP of US Ambulatory Surgery Centers at DePuy Synthes, The Orthopaedics Company of Johnson & Johnson, to discuss the state of the ASC market, capabilities in this space, and emerging technologies relevant to this site of care. Tune in to learn more about growth opportunities in the ASC market and the future of robotics in the ASC space. This podcast is sponsored by Johnson & Johnson.
Summary
The Future of Robotics in ASCs: A Conversation With Carol Stanfill
Introduction
In this episode, we are joined by Carol Stanfill the VP of US Ambulatory Surgery Centers at DePuy Synthes, The Orthopaedics Company of Johnson & Johnson, to discuss the state of the ASC market, capabilities in this space, and emerging technologies relevant to this site of care. Tune in to learn more about growth opportunities in the ASC market and the future of robotics in the ASC space. This podcast is sponsored by Johnson & Johnson.
The Advancements in Technology and Pain Management
Carol Stanfill, the Vice President of US Ambulatory Surgery Centers at DePuy, explained how the advances in technology and pain management have allowed surgeries to move into ambulatory surgery centers (ASCs). This shift has enabled patients to have shorter hospital stays, faster recovery times, and less pain. It has also allowed ASCs to expand their scope from low-acuity outpatient procedures to higher-acuity procedures.
The Future of Robotics in ASCs
Carol also discussed the future of robotics in ASCs. One example she mentioned was the VES Robotic Assisted Solution for knee arthroplasty. This technology allows for more precise joint reconstruction and a shorter recovery time. Carol believes that the use of robotics in ASCs will continue to grow as the technology becomes more advanced and cost-effective.
Depu Synthes' Commitment to ASCs
Depu Synthes is focused on helping ASCs maximize their efficiency and manage their volume with customized solutions to address the needs of surgeons, entrepreneurs, and administrators. They also aim to raise the standard of patient satisfaction with implants, technologies, and workflow solutions that are based on clinical excellence, economic value, and operational support.
Overall, the future of ASCs looks bright with the advancements in technology, pain management, and the use of robotics. As the demand for outpatient procedures increases, ASCs will continue to evolve and offer more advanced procedures with shorter recovery times.
Note: This is an AI generated transcript, not edited by a staff writer and is solely intended for educational purposes. If you have any questions/concerns, reach out to podcasts@beckershealthcare.com
This episode aired on 10/06/2022 and can be listened here.
Subscribe to Beckers Healthcare Podcast here.